This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Obamacare's Fate Must Wait Until June

NEW YORK ( TheStreet) -- The U.S. Supreme Court will start to hear oral arguments Monday of the Patient Protection and Affordable Care Act, which is now referred to by President Barack Obama as "Obamacare."

The six hours of hearings across three days won't produce any decisions, but will set the stage for a June showdown between the Obama administration and 26 states opposed to the massive overhaul of health insurance in the U.S.

A June decision would come some five months ahead of the 2012 election for president as opponents and supporters of the health insurance law are likely to use the Supreme Court's judgment as a central theme to November's political maelstrom.

"Can you imagine if the opposition called Social Security "Roosevelt Security"? Or if Medicare was "LBJ-Care"? Seriously, have these guys ever heard of the long view?" David Axelrod, a top strategist for Obama's re-election campaign, wrote in a statement on Friday.

Republicans have typically used the term Obamacare in a pejorative way and presidential hopeful Rick Santorum has even said that his candidacy has focused on the need to repeal the legislation.

Mitt Romney has tread lightly around the issue as critics have pointed to a Massachusetts health care reform -- passed in 2006 and signed into law by Romney when he was governor there -- as the model for Obamacare.

The GOP presidential front-runner has consistently said the Massachusetts law and the Affordable Care Act passed by Congress are different, and he hasn't refrained from criticizing the president's plan.

"Sadly, the law itself is fast becoming the national nightmare that I and other critics have always predicted," Romney said in a statement on Friday.

The Supreme Court will hear 90 minutes of oral arguments Monday, according to the court's Web site.

-- Written by Joe Deaux in New York.

>Contact by Email.

>Follow Joe Deaux on Twitter. Subscribe on Facebook.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $110.38 0.00%
FB $92.07 0.00%
GOOG $626.91 0.00%
TSLA $247.57 0.00%
YHOO $30.71 0.00%


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs